| Bioactivity | Denibulin, a novel vascular-disrupting agent, inhibits microtubule assembly reversibly, disrupting tumor vascular endothelial cell cytoskeletons. Denibulin demonstrated tolerability and potential anti-vascular effects, warranting further investigation in cancer therapy[1]. |
| CAS | 284019-34-7 |
| Formula | C18H19N5O3S |
| Molar Mass | 385.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Denibulin
CAS: 284019-34-7 F: C18H19N5O3S W: 385.44
Denibulin, a novel vascular-disrupting agent, inhibits microtubule assembly reversibly, disrupting tumor vascular endoth
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.